Showing results (2231-2240 of 2,253) with videos related to
Sort By:
Pageof 226
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 11, 2021
A Survey of Chinese Pig Farms and Human Healthcare Isolates Reveals Separate Human and Animal Methicillin-Resistant Staphylococcus aureus PopulationsGeng Zou, Marta Matuszewska, Ming Jia, et al.Nature Communications|May 4, 2019
Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancerRui Xing, Yong Zhou, Jun Yu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 6, 2021
Updated Overall Survival Data and Predictive Biomarkers of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC in the Phase 3 ORIENT-11 StudyYunpeng Yang, Jiya Sun, Zhehai Wang, et al.Nature|August 28, 2024
Superconductivity under pressure in a chromium-based kagome metalYi Liu, Zi-Yi Liu, Jin-Ke Bao, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 29, 2025
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical TrialsZhaojun Wang, Yiran Fang, Xiatong Huang, et al.Transplantation and Cellular Therapy|July 6, 2021
A Scoring System for Predicting the Prognosis of Late-Onset Severe Pneumonia after Allogeneic Hematopoietic Stem Cell TransplantationLe-Qing Cao, Jing-Rui Zhou, Xiao-Hui Zhang, et al.Cell Genomics|October 10, 2024
Genetic analyses of 104 phenotypes in 20,900 Chinese pregnant women reveal pregnancy-specific discoveriesHan Xiao, Linxuan Li, Meng Yang, et al.Med (New York, N.Y.)|August 1, 2024
Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trialMin Shi, Dongqiang Zeng, Huiyan Luo, et al.Science Advances|April 13, 2022
Mitolysosome exocytosis, a mitophagy-independent mitochondrial quality control in flunarizine-induced parkinsonism-like symptomsFeixiang Bao, Lingyan Zhou, Rui Zhou, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2020
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)Yunpeng Yang, Zhehai Wang, Jian Fang, et al.Pageof 226